These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19672984)

  • 1. LRRK2 R1628P variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China.
    Zhang Z; Burgunder JM; An X; Wu Y; Chen W; Zhang J; Wang Y; Xu Y; Gou Y; Yuan G; Mao X; Peng R
    Mov Disord; 2009 Oct; 24(13):1902-5. PubMed ID: 19672984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LRRK2 Gly2385Arg variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China.
    An XK; Peng R; Li T; Burgunder JM; Wu Y; Chen WJ; Zhang JH; Wang YC; Xu YM; Gou YR; Yuan GG; Zhang ZJ
    Eur J Neurol; 2008 Mar; 15(3):301-5. PubMed ID: 18201193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LRRK2 R1628P contributes to Parkinson's disease susceptibility in Chinese Han populations from mainland China.
    Yu L; Hu F; Zou X; Jiang Y; Liu Y; He X; Xi J; Liu L; Liu Z; He L; Xu Y
    Brain Res; 2009 Nov; 1296():113-6. PubMed ID: 19699188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of LRRK2 R1628P variant with Parkinson's disease in Ethnic Han-Chinese and subgroup population.
    Zhang P; Wang Q; Jiao F; Yan J; Chen L; He F; Zhang Q; Tian B
    Sci Rep; 2016 Nov; 6():35171. PubMed ID: 27812003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The LRRK2 G2385R variant is a risk factor for sporadic Parkinson's disease in the Korean population.
    Kim JM; Lee JY; Kim HJ; Kim JS; Shin ES; Cho JH; Park SS; Jeon BS
    Parkinsonism Relat Disord; 2010 Feb; 16(2):85-8. PubMed ID: 19854095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease.
    Ross OA; Wu YR; Lee MC; Funayama M; Chen ML; Soto AI; Mata IF; Lee-Chen GJ; Chen CM; Tang M; Zhao Y; Hattori N; Farrer MJ; Tan EK; Wu RM
    Ann Neurol; 2008 Jul; 64(1):88-92. PubMed ID: 18412265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Confirmation of the association between LRRK2 R1628P variant and susceptibility to Parkinson's disease in the Thai population.
    Pulkes T; Papsing C; Thakkinstian A; Pongpakdee S; Kulkantrakorn K; Hanchaiphiboolkul S; Tiamkao S; Boonkongchuen P
    Parkinsonism Relat Disord; 2014 Sep; 20(9):1018-21. PubMed ID: 24997548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between G2385R and R1628P polymorphism of LRRK2 gene and sporadic Parkinson's disease in a Han-Chinese population in south-eastern China.
    Cai J; Lin Y; Chen W; Lin Q; Cai B; Wang N; Zheng W
    Neurol Sci; 2013 Nov; 34(11):2001-6. PubMed ID: 23624603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between LRRK2 R1628P polymorphism and Parkinson's disease in Asian populations.
    Zhao H; Kong Z
    Oncotarget; 2016 Jul; 7(30):46890-46898. PubMed ID: 27384489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lrrk2 R1628P variant is a risk factor for essential tremor.
    Chao YX; Ng EY; Tan L; Prakash KM; Au WL; Zhao Y; Tan EK
    Sci Rep; 2015 Mar; 5():9029. PubMed ID: 25761573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between GBA L444P mutation and sporadic Parkinson's disease from Mainland China.
    Mao XY; Burgunder JM; Zhang ZJ; An XK; Zhang JH; Yang Y; Li T; Wang YC; Chang XL; Peng R
    Neurosci Lett; 2010 Jan; 469(2):256-9. PubMed ID: 20004703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A common genetic factor for Parkinson disease in ethnic Chinese population in Taiwan.
    Fung HC; Chen CM; Hardy J; Singleton AB; Wu YR
    BMC Neurol; 2006 Dec; 6():47. PubMed ID: 17187665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An association analysis of the R1628P and G2385R polymorphisms of the LRRK2 gene in multiple system atrophy in a Chinese population.
    Yuan X; Chen Y; Cao B; Zhao B; Wei Q; Guo X; Yang Y; Yuan L; Shang H
    Parkinsonism Relat Disord; 2015 Feb; 21(2):147-9. PubMed ID: 25511328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lrrk2 R1628P in non-Chinese Asian races.
    Tan EK; Tang M; Tan LC; Wu YR; Wu RM; Ross OA; Zhao Y
    Ann Neurol; 2008 Oct; 64(4):472-3. PubMed ID: 18688798
    [No Abstract]   [Full Text] [Related]  

  • 15. LRRK2 R1628P increases risk of Parkinson's disease: replication evidence.
    Tan EK; Tan LC; Lim HQ; Li R; Tang M; Yih Y; Pavanni R; Prakash KM; Fook-Chong S; Zhao Y
    Hum Genet; 2008 Oct; 124(3):287-8. PubMed ID: 18781329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LRRK2 G2385R and LRRK2 R1628P increase risk of Parkinson's disease in a Han Chinese population from Southern Mainland China.
    Fu X; Zheng Y; Hong H; He Y; Zhou S; Guo C; Liu Y; Xian W; Zeng J; Li J; Liu Z; Chen L; Pei Z
    Parkinsonism Relat Disord; 2013 Mar; 19(3):397-8. PubMed ID: 22981185
    [No Abstract]   [Full Text] [Related]  

  • 17. Confirmation of LRRK2 S1647T variant as a risk factor for Parkinson's disease in southern China.
    Zheng Y; Liu Y; Wu Q; Hong H; Zhou H; Chen J; Wang H; Xian W; Li J; Liu Z; Pei Z; Chen L
    Eur J Neurol; 2011 Mar; 18(3):538-40. PubMed ID: 20629711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel P755L mutation in LRRK2 gene associated with Parkinson's disease.
    Wu T; Zeng Y; Ding X; Li X; Li W; Dong H; Chen S; Zhang X; Ma G; Yao J; Deng X
    Neuroreport; 2006 Dec; 17(18):1859-62. PubMed ID: 17179858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence.
    Tan EK; Zhao Y; Skipper L; Tan MG; Di Fonzo A; Sun L; Fook-Chong S; Tang S; Chua E; Yuen Y; Tan L; Pavanni R; Wong MC; Kolatkar P; Lu CS; Bonifati V; Liu JJ
    Hum Genet; 2007 Feb; 120(6):857-63. PubMed ID: 17019612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.
    Ross OA; Soto-Ortolaza AI; Heckman MG; Aasly JO; Abahuni N; Annesi G; Bacon JA; Bardien S; Bozi M; Brice A; Brighina L; Van Broeckhoven C; Carr J; Chartier-Harlin MC; Dardiotis E; Dickson DW; Diehl NN; Elbaz A; Ferrarese C; Ferraris A; Fiske B; Gibson JM; Gibson R; Hadjigeorgiou GM; Hattori N; Ioannidis JP; Jasinska-Myga B; Jeon BS; Kim YJ; Klein C; Kruger R; Kyratzi E; Lesage S; Lin CH; Lynch T; Maraganore DM; Mellick GD; Mutez E; Nilsson C; Opala G; Park SS; Puschmann A; Quattrone A; Sharma M; Silburn PA; Sohn YH; Stefanis L; Tadic V; Theuns J; Tomiyama H; Uitti RJ; Valente EM; van de Loo S; Vassilatis DK; Vilariño-Güell C; White LR; Wirdefeldt K; Wszolek ZK; Wu RM; Farrer MJ;
    Lancet Neurol; 2011 Oct; 10(10):898-908. PubMed ID: 21885347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.